Arkansas Senate Bill SB358

Arkansas 2023 Regular Session

• Introduced: 3/3/23
• Refer: 3/6/23
• Refer: 3/13/23
• Report Pass: 3/14/23
• Engrossed: 3/15/23
• Refer: 3/15/23
• Report Pass: 3/30/23
• Refer: 4/5/23
• Report Pass: 4/5/23
• Refer: 4/6/23
• Report Pass: 4/6/23
• Enrolled: 4/7/23
• Chaptered: 4/11/23
• Passed: 4/11/23

Caption

To Prohibit Industrial Hemp That Contain Certain Delta Tetrahydrocannabinol Substances; To Include Certain Tetrahydrocannabinol In The List Of Schedule Vi Controlled Substances; And To Declare An Emergency.

Impact

Should SB358 be enacted, it would lead to significant changes in how industrial hemp is regulated within Arkansas. The bill allows for the cultivation of hemp strictly for non-psychoactive uses while prohibiting any form of products that are deemed intoxicating. This strong regulatory approach is perceived as necessary by some to protect the public and especially youths from potential health risks associated with intoxicating substances. However, it may limit opportunities for hemp farmers and businesses that may have hoped to enter into markets involving these newly controlled substances.

Summary

Senate Bill 358 aims to prohibit the production, processing, and sale of industrial hemp that contains certain tetrahydrocannabinol (THC) substances, specifically delta-8, delta-9, and delta-10 THC. The bill proposes to amend existing laws to classify these substances as Schedule VI controlled substances, thereby increasing regulatory oversight on their distribution. Such actions are motivated by concerns regarding public health and safety, particularly in preventing minors from accessing intoxicating substances derived from industrial hemp.

Sentiment

The sentiment surrounding SB358 is mixed. Proponents argue that stricter regulations are essential for safeguarding public health and preventing the potential abuse of hemp-derived products. They believe that enforcing controls will mitigate risks associated with such substances. On the contrary, critics express concern that the bill could hinder economic growth in the burgeoning hemp industry by over-regulating producers and restrict legitimate business opportunities connected to hemp-derived products.

Contention

One of the key points of contention regarding SB358 revolves around the balance between regulation and commerce. Opponents raise concerns that the blanket prohibition on certain THC-containing products may not adequately consider the regulatory hurdles placed upon lawful hemp businesses. Furthermore, the classification of delta-8 and delta-10 THC as controlled substances creates potential challenges for consumers and businesses alike, raising questions about market access and consumer choice in a rapidly evolving industry.